-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CgY+nSd9t9fiw0YY1l24p/+O13bjod9YncufRph0WBP18lLhe7Qsl8koZqeFbC5/ R2MJU+BZTBpmMbg6O40qHQ== 0000739944-98-000007.txt : 19980624 0000739944-98-000007.hdr.sgml : 19980624 ACCESSION NUMBER: 0000739944-98-000007 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 19980603 ITEM INFORMATION: FILED AS OF DATE: 19980623 SROS: AMEX FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDTOX SCIENTIFIC INC CENTRAL INDEX KEY: 0000739944 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 953863205 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: SEC FILE NUMBER: 001-11394 FILM NUMBER: 98652305 BUSINESS ADDRESS: STREET 1: 402 WEST COUNTY ROAD D CITY: ST PAUL STATE: MN ZIP: 55112 BUSINESS PHONE: 6126367466 MAIL ADDRESS: STREET 1: 402 WEST COUNTY ROAD D CITY: ST PAUL STATE: MN ZIP: 55112 FORMER COMPANY: FORMER CONFORMED NAME: EDITEK INC DATE OF NAME CHANGE: 19940902 FORMER COMPANY: FORMER CONFORMED NAME: ENVIRONMENTAL DIAGNOSTICS INC DATE OF NAME CHANGE: 19920703 8-K/A 1 FORM 8-K/A-2 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 1998 MEDTOX SCIENTIFIC, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-11394 95-3863205 (Commission File Number) (IRS Employer Identification No.) 402 West County Road D St. Paul, Minnesota 55112 (Address of principal executive offices) (Zip Code) (612) 636-7466 (Registrant's telephone number, including area code) Item 4. Change In Independent Accountants Effective May 27, 1998, the Registrant terminated Ernst & Young LLP as its independent accounting firm. Exhibit 16 is the response of Ernst & Young LLP to the disclosures made by the Registrant on Form 8-K/A dated June 3, 1998. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MEDTOX Scientific, Inc. Date: June 23, 1998 By: /s/ Peter J. Heath Name: Peter J. Heath Title: Vice President of Finance and Chief Financial Officer EX-16 2 Exhibit 16 ERNST & YOUNG LLP 1400 Pillsbury Center Phone: 612 343 1000 Minneapolis Minnesota 55402-1491 June 17, 1998 Securities and Exchange Commission 450 Fifth Street NW Washington, D.C. 2049 Gentlemen: We have read Item 4 of Form 8-K/A dated June 3, 1998 of Medtox Scientific, Inc. and are in agreement with the statements contained in the first four paragraphs of page 2 therein, except as follows: 1. We have no basis to agree or disagree with the second sentence of the first paragraph of page 2 and, 2. The words "through May 27, 1998" should be placed after the word "Registrant" in the first line of the fourth paragraph of page 2. We have no basis to agree or disagree with other statements of the registrant contained therein. /s/ Ernst & Young LLP -----END PRIVACY-ENHANCED MESSAGE-----